Galapagos

  • Galapagos placed 2,696,831 shares (10% of outstanding shares) in the accelerated bookbuild offering
  • Participating investors were mainly located in the US, and predominantly included specialist healthcare investors
  • Kempen & Co acted as Joint Bookrunner, combining supply and demand in order not to put unnecessary pressure on the share price